Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world pharmacoeconomic study of Huatuo Zaizao Pills for acute ischemic stroke
ChiCTR2200058278Phase 4Not yet recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Feb 2022
- Countries
- 1
01
Overview
Phase 4, open-label trial of Huatuo Zaizao in ischemic stroke and confusion (2 arms), sponsored by Nanjing Drum-Tower Hospital. Primary endpoints: Change in NIHSS score, Disability rate and 9 more. Planned start Feb 2022; status: not yet recruiting.
02
Drugs
Huatuo Zaizao
03
Conditions
ischemic strokeconfusion
Beyond the preview
Go deeper on ChiCTR2200058278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200058278.